Drug
Astringent
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Joint Dislocation | 151 | 164.6 | 179.1 | signal |
| 2 | Wound Infection | 145 | 152.9 | 165.8 | signal |
| 3 | Hypercholesterolaemia | 127 | 152.1 | 163.3 | signal |
| 4 | Joint Range Of Motion Decreased | 152 | 130.1 | 141.6 | signal |
| 5 | Helicobacter Infection | 109 | 122.2 | 129.8 | signal |
| 6 | Pemphigus | 124 | 113.9 | 122.0 | signal |
| 7 | Laryngitis | 98 | 103.0 | 108.7 | signal |
| 8 | Pericarditis | 143 | 97.9 | 106.0 | signal |
| 9 | Folliculitis | 83 | 91.6 | 95.8 | signal |
| 10 | Red Blood Cell Sedimentation Rate Increased | 87 | 89.4 | 93.8 | signal |
| 11 | Sciatica | 124 | 89.1 | 95.4 | signal |
| 12 | Irritable Bowel Syndrome | 160 | 85.3 | 93.3 | signal |
| 13 | Prescribed Underdose | 147 | 84.0 | 91.1 | signal |
| 14 | Autoimmune Disorder | 68 | 80.9 | 84.0 | signal |
| 15 | Hip Arthroplasty | 96 | 71.9 | 75.8 | signal |
| 16 | Foot Deformity | 70 | 71.8 | 74.6 | signal |
| 17 | Joint Stiffness | 155 | 67.2 | 73.2 | signal |
| 18 | Hand Deformity | 76 | 66.1 | 68.9 | signal |
| 19 | Wound | 156 | 63.8 | 69.6 | signal |
| 20 | Synovitis | 101 | 63.6 | 67.3 | signal |
| 21 | Pulmonary Fibrosis | 101 | 60.1 | 63.5 | signal |
| 22 | Type 2 Diabetes Mellitus | 178 | 59.9 | 66.2 | signal |
| 23 | Prescribed Overdose | 101 | 59.3 | 62.7 | signal |
| 24 | Lower Limb Fracture | 94 | 55.9 | 58.9 | signal |
| 25 | Knee Arthroplasty | 97 | 52.9 | 55.7 | signal |
| 26 | Liver Function Test Increased | 99 | 52.7 | 55.7 | signal |
| 27 | Fibromyalgia | 108 | 50.5 | 53.6 | signal |
| 28 | Liver Injury | 104 | 48.8 | 51.7 | signal |
| 29 | Hepatic Cirrhosis | 74 | 45.0 | 46.8 | signal |
| 30 | Impaired Healing | 129 | 44.6 | 47.9 | signal |
| 31 | Osteoarthritis | 154 | 41.2 | 44.8 | signal |
| 32 | Glossodynia | 78 | 39.6 | 41.3 | signal |
| 33 | Gait Inability | 115 | 39.4 | 42.0 | signal |
| 34 | Psoriatic Arthropathy | 136 | 38.4 | 41.3 | signal |
| 35 | Osteoporosis | 136 | 37.5 | 40.4 | signal |
| 36 | Upper Respiratory Tract Infection | 146 | 35.9 | 38.9 | signal |
| 37 | Road Traffic Accident | 129 | 35.0 | 37.5 | signal |
| 38 | Systemic Lupus Erythematosus | 109 | 35.0 | 37.1 | signal |
| 39 | Disability | 59 | 33.8 | 34.9 | signal |
| 40 | Wheezing | 158 | 30.3 | 33.0 | signal |
| 41 | C-reactive Protein Increased | 94 | 29.3 | 30.8 | signal |
| 42 | Ear Infection | 67 | 28.6 | 29.7 | signal |
| 43 | Drug-induced Liver Injury | 75 | 27.6 | 28.7 | signal |
| 44 | Uveitis | 31 | 26.0 | 26.4 | signal |
| 45 | Oedema | 124 | 26.0 | 27.8 | signal |
| 46 | Infusion Related Reaction | 149 | 25.6 | 27.7 | signal |
| 47 | Sleep Disorder Due To A General Medical Condition | 36 | 25.2 | 25.7 | signal |
| 48 | Delirium | 75 | 24.6 | 25.6 | signal |
| 49 | Blood Cholesterol Increased | 93 | 22.6 | 23.7 | signal |
| 50 | Mobility Decreased | 142 | 22.5 | 24.2 | signal |
| 51 | Injury | 126 | 20.2 | 21.6 | signal |
| 52 | Intraocular Pressure Increased | 22 | 19.4 | 19.6 | signal |
| 53 | Loss Of Personal Independence In Daily Activities | 77 | 18.3 | 19.1 | signal |
| 54 | Sensory Disturbance | 26 | 18.3 | 18.5 | signal |
| 55 | Breast Cancer Stage I | 15 | 18.1 | 18.2 | signal |
| 56 | Poisoning | 20 | 18.0 | 18.1 | signal |
| 57 | Bursitis | 19 | 17.8 | 18.0 | signal |
| 58 | Hepatic Enzyme Increased | 101 | 16.8 | 17.7 | signal |
| 59 | Musculoskeletal Stiffness | 130 | 16.8 | 18.0 | signal |
| 60 | Obstructive Airways Disorder | 16 | 16.2 | 16.4 | signal |
| 61 | Stomatitis | 82 | 15.3 | 16.0 | signal |
| 62 | Contusion | 128 | 15.1 | 16.1 | signal |
| 63 | Psoriasis | 174 | 15.1 | 16.5 | signal |
| 64 | Arthropathy | 73 | 14.8 | 15.4 | signal |
| 65 | Completed Suicide | 107 | 14.4 | 15.2 | signal |
| 66 | Blister | 71 | 14.3 | 14.9 | signal |
| 67 | Sinusitis | 129 | 14.2 | 15.2 | signal |
| 68 | Visual Impairment | 153 | 14.1 | 15.3 | signal |
| 69 | Infection | 178 | 14.0 | 15.4 | signal |
| 70 | Poor Quality Sleep | 25 | 13.2 | 13.4 | signal |
| 71 | Amnesia | 76 | 13.2 | 13.7 | signal |
| 72 | Discomfort | 69 | 12.9 | 13.3 | signal |
| 73 | Pulmonary Congestion | 15 | 12.8 | 12.9 | signal |
| 74 | Tachycardia | 100 | 12.7 | 13.4 | signal |
| 75 | Urticaria | 184 | 12.5 | 13.8 | signal |
| 76 | Hypoaesthesia | 165 | 12.5 | 13.6 | signal |
| 77 | Erectile Dysfunction | 28 | 12.3 | 12.5 | signal |
| 78 | Oedema Peripheral | 131 | 12.1 | 13.0 | signal |
| 79 | Muscular Weakness | 120 | 12.0 | 12.7 | signal |
| 80 | Peripheral Swelling | 156 | 11.5 | 12.5 | signal |
| 81 | Back Injury | 11 | 11.5 | 11.6 | signal |
| 82 | Asthma | 110 | 11.1 | 11.7 | signal |
| 83 | Toxicity To Various Agents | 162 | 10.9 | 11.9 | signal |
| 84 | General Physical Health Deterioration | 109 | 10.7 | 11.3 | signal |
| 85 | Joint Swelling | 114 | 10.7 | 11.3 | signal |
| 86 | Swelling | 88 | 10.7 | 11.1 | signal |
| 87 | Rheumatoid Arthritis | 104 | 10.4 | 11.0 | signal |
| 88 | Coeliac Disease | 9 | 10.4 | 10.4 | signal |
| 89 | Bronchitis | 67 | 10.2 | 10.5 | signal |
| 90 | Obesity | 14 | 9.9 | 10.0 | signal |
| 91 | Ear Pain | 17 | 9.9 | 10.0 | signal |
| 92 | Visual Acuity Reduced | 29 | 9.8 | 9.9 | signal |
| 93 | Arthritis | 68 | 9.8 | 10.1 | signal |
| 94 | Hypertension | 181 | 9.7 | 10.6 | signal |
| 95 | Nasopharyngitis | 155 | 9.5 | 10.3 | signal |
| 96 | Rash Macular | 29 | 9.4 | 9.6 | signal |
| 97 | Hypersensitivity | 154 | 9.4 | 10.2 | signal |
| 98 | Weight Increased | 183 | 9.3 | 10.2 | signal |
| 99 | Dysuria | 30 | 9.2 | 9.3 | signal |
| 100 | Dyspepsia | 79 | 9.1 | 9.5 | signal |
| 101 | Intentional Product Use Issue | 69 | 8.9 | 9.2 | signal |
| 102 | Poor Quality Product Administered | 8 | 8.9 | 8.9 | signal |
| 103 | Memory Impairment | 107 | 8.8 | 9.3 | signal |
| 104 | Therapeutic Product Effect Incomplete | 55 | 8.8 | 9.0 | signal |
| 105 | Sleep Disorder | 54 | 8.7 | 9.0 | signal |
| 106 | Contraindicated Product Administered | 22 | 8.3 | 8.3 | signal |
| 107 | Skin Discolouration | 33 | 8.1 | 8.3 | signal |
| 108 | Drug Intolerance | 69 | 8.1 | 8.4 | signal |
| 109 | Scab | 8 | 8.0 | 8.0 | signal |
| 110 | Abdominal Discomfort | 116 | 7.9 | 8.3 | signal |
| 111 | Skin Haemorrhage | 10 | 7.8 | 7.9 | signal |
| 112 | Scratch | 7 | 7.7 | 7.7 | signal |
| 113 | Weight Decreased | 188 | 7.6 | 8.4 | signal |
| 114 | Lower Respiratory Tract Infection | 30 | 7.5 | 7.6 | signal |
| 115 | Hypoglycaemia | 32 | 7.5 | 7.6 | signal |
| 116 | Incorrect Route Of Product Administration | 11 | 7.4 | 7.4 | signal |
| 117 | Drug Toxicity | 9 | 7.4 | 7.4 | signal |
| 118 | Skin Fissures | 12 | 7.2 | 7.2 | signal |
| 119 | Productive Cough | 30 | 7.2 | 7.3 | signal |
| 120 | Eye Pain | 35 | 7.2 | 7.3 | signal |
| 121 | Neurotoxicity | 11 | 7.2 | 7.2 | signal |
| 122 | Heart Rate Decreased | 22 | 7.1 | 7.1 | signal |
| 123 | Micturition Urgency | 7 | 7.0 | 7.0 | signal |
| 124 | Renal Tubular Necrosis | 6 | 6.9 | 6.9 | signal |
| 125 | Condition Aggravated | 184 | 6.9 | 7.5 | signal |
| 126 | Confusional State | 98 | 6.8 | 7.2 | signal |
| 127 | Metabolic Acidosis | 19 | 6.8 | 6.9 | signal |
| 128 | Chest Pain | 110 | 6.7 | 7.1 | signal |
| 129 | Pain In Extremity | 169 | 6.5 | 7.0 | signal |
| 130 | Epilepsy | 17 | 6.3 | 6.4 | signal |
| 131 | Renal Disorder | 26 | 6.3 | 6.4 | signal |
| 132 | Brain Oedema | 7 | 6.3 | 6.3 | signal |
| 133 | Taste Disorder | 11 | 6.2 | 6.2 | signal |
| 134 | Inflammation | 28 | 6.2 | 6.3 | signal |
| 135 | Immunodeficiency | 8 | 6.1 | 6.2 | signal |
| 136 | Pruritus | 205 | 6.1 | 6.8 | signal |
| 137 | Gait Disturbance | 104 | 6.1 | 6.4 | signal |
| 138 | Skin Infection | 6 | 6.1 | 6.1 | signal |
| 139 | Immune System Disorder | 7 | 6.0 | 6.0 | signal |
| 140 | Lung Disorder | 26 | 6.0 | 6.1 | signal |
| 141 | Alopecia | 104 | 6.0 | 6.3 | signal |
| 142 | Spinal Disorder | 5 | 6.0 | 6.0 | signal |
| 143 | Posterior Reversible Encephalopathy Syndrome | 5 | 5.9 | 6.0 | signal |
| 144 | Ankle Fracture | 8 | 5.8 | 5.9 | signal |
| 145 | Post Procedural Haemorrhage | 6 | 5.8 | 5.8 | signal |
| 146 | Acute Respiratory Distress Syndrome | 9 | 5.8 | 5.8 | signal |
| 147 | Hypomagnesaemia | 7 | 5.7 | 5.7 | signal |
| 148 | Wrong Technique In Device Usage Process | 23 | 5.7 | 5.8 | signal |
| 149 | Gallbladder Disorder | 9 | 5.7 | 5.7 | signal |
| 150 | Movement Disorder | 16 | 5.6 | 5.7 | signal |
| 151 | Back Disorder | 8 | 5.5 | 5.6 | signal |
| 152 | Cataract | 29 | 5.5 | 5.6 | signal |
| 153 | Acne | 37 | 5.5 | 5.6 | signal |
| 154 | Pain Of Skin | 13 | 5.4 | 5.5 | signal |
| 155 | Cardio-respiratory Arrest | 20 | 5.4 | 5.4 | signal |
| 156 | Scar | 8 | 5.3 | 5.3 | signal |
| 157 | Adverse Event | 42 | 5.2 | 5.3 | signal |
| 158 | Quality Of Life Decreased | 6 | 5.1 | 5.1 | signal |
| 159 | Device Defective | 7 | 4.9 | 4.9 | signal |
| 160 | Squamous Cell Carcinoma | 4 | 4.8 | 4.8 | signal |
| 161 | Product Prescribing Error | 10 | 4.8 | 4.8 | signal |
| 162 | Nasal Congestion | 24 | 4.6 | 4.7 | signal |
| 163 | Inflammatory Bowel Disease | 4 | 4.6 | 4.6 | signal |
| 164 | Fluid Overload | 6 | 4.6 | 4.6 | signal |
| 165 | Therapeutic Product Effect Decreased | 18 | 4.6 | 4.6 | signal |
| 166 | Adverse Drug Reaction | 36 | 4.6 | 4.6 | signal |
| 167 | Respiratory Arrest | 11 | 4.5 | 4.5 | signal |
| 168 | Limb Discomfort | 12 | 4.4 | 4.4 | signal |
| 169 | Treatment Failure | 31 | 4.3 | 4.3 | signal |
| 170 | Jaundice | 10 | 4.2 | 4.2 | signal |
| 171 | Fracture | 7 | 4.2 | 4.2 | signal |
| 172 | Therapeutic Response Decreased | 22 | 4.1 | 4.2 | signal |
| 173 | Pruritus Generalised | 8 | 4.1 | 4.1 | signal |
| 174 | Maternal Exposure During Pregnancy | 31 | 4.0 | 4.0 | signal |
| 175 | Pregnancy | 7 | 3.9 | 3.9 | signal |
| 176 | Spinal Pain | 4 | 3.9 | 3.9 | signal |
| 177 | Accident | 4 | 3.8 | 3.8 | signal |
| 178 | Product Dispensing Error | 7 | 3.6 | 3.7 | signal |
| 179 | Product Complaint | 8 | 3.6 | 3.6 | signal |
| 180 | Ill-defined Disorder | 19 | 3.5 | 3.6 | signal |
| 181 | Drug Abuse | 26 | 3.5 | 3.6 | signal |
| 182 | Malignant Melanoma | 4 | 3.4 | 3.4 | signal |
| 183 | Injection Site Urticaria | 7 | 3.3 | 3.3 | signal |
| 184 | Colitis Ulcerative | 12 | 3.0 | 3.1 | signal |
| 185 | Intentional Overdose | 17 | 3.0 | 3.0 | signal |
| 186 | Haemorrhage Intracranial | 4 | 3.0 | 3.0 | no signal |
| 187 | Status Epilepticus | 3 | 3.0 | 3.0 | no signal |
| 188 | Cytokine Release Syndrome | 5 | 3.0 | 3.0 | signal |
| 189 | Tendon Rupture | 3 | 2.7 | 2.7 | no signal |
| 190 | Muscle Spasticity | 3 | 2.7 | 2.7 | no signal |
| 191 | Extrapyramidal Disorder | 6 | 2.7 | 2.7 | signal |
| 192 | Injection Site Reaction | 15 | 2.5 | 2.5 | signal |
| 193 | Prostatic Specific Antigen Increased | 3 | 2.4 | 2.5 | no signal |
| 194 | Incorrect Product Administration Duration | 4 | 2.2 | 2.2 | no signal |
| 195 | Product Storage Error | 13 | 1.7 | 1.7 | no signal |
| 196 | Needle Issue | 4 | 1.6 | 1.6 | no signal |
| 197 | Device Difficult To Use | 9 | 1.5 | 1.5 | no signal |
| 198 | Device Malfunction | 7 | 1.2 | 1.2 | no signal |
| 199 | Dermatitis Atopic | 5 | 1.1 | 1.1 | no signal |
| 200 | Drug Exposure During Pregnancy | 3 | 1.0 | 1.0 | no signal |
| 201 | Drug Withdrawal Syndrome | 7 | 0.9 | 0.9 | no signal |
| 202 | Bladder Cancer | 3 | 0.6 | 0.6 | no signal |